The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
about
Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesMechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide developmentAntiviral activity of animal venom peptides and related compoundsAcyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora"Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosaDevelopment of topical microbicides to prevent the sexual transmission of HIVPeptide-based Antifungal Therapies against Emerging Infections.Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.Modeling mucosal cell-associated HIV type 1 transmission in vitro.Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entryAntileishmanial and antitrypanosomal activity of the cutaneous secretion of Siphonops annulatusDifferential in vitro inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose specific plant lectins: implication for microbicide developmentAnti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsMucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivoNatural antimicrobial peptides as promising anti-HIV candidates.Peptide antimicrobial agents.Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review.Therapeutic approaches using host defence peptides to tackle herpes virus infections.Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidinsProteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.Evaluation of the in vitro activity of dermaseptin 01, a cationic antimicrobial peptide, against Schistosoma mansoni.In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.In vitro activities of dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation.Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers.Dermaseptin S4 derivative K4K20S4: a potential candidate for development of a new microbicide contraceptive agent--an in vitro study.Current trends and perspectives of bioactive peptides.Heterologous expression and purification of dermaseptin S4 fusion in Escherichia coli and recovery of biological activity.Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway.Dermaseptin 01 as antimicrobial peptide with rich biotechnological potential: study of peptide interaction with membranes containing Leishmania amazonensis lipid-rich extract and membrane modelsDiscovery of Peptide Drugs from Natural Sources
P2860
Q26751499-BB403D44-A603-46B2-8A2B-2855FEC4B90CQ26765450-C452398F-0732-442F-A3B1-897DA06986CFQ28257799-CF5C0AC5-6429-46F9-9E23-89AAF020878AQ28353903-AB6F8D40-AE78-4B67-9E74-5237C338C563Q33260522-57862E3C-D38D-48FA-9317-FCEB9D73CF7BQ33584712-0CFECDFD-6A5A-4C92-905C-C0F202D547A6Q33625073-6DB492F9-23EB-4FD1-84A7-4BB288577F7FQ33862289-9C78CE1B-E128-4890-931A-63E2D1A074B8Q34541093-0A72A95F-99A1-4B4F-9853-04CD538C86E3Q35000072-F782A16F-5542-4124-BEC8-5566ABCD779EQ35024210-28FC7F60-8B70-4830-ABA5-B19E856E1D07Q35413035-0B8DCBAE-61FF-4801-B168-13AA65CAB935Q35865143-585259B5-B434-477D-93E2-5F764B6871EBQ35868058-090F5F01-4C82-4584-8056-315054999360Q36216315-E5EC9B7F-3A89-40CA-BCCA-71ED38374149Q36514316-B4D6A0FF-506D-417E-B17B-0124733BBFC1Q36538861-0B86CB18-F91D-411B-8E67-1B20EF9C7961Q37412040-5A3BD1B6-F09D-4F4A-A70B-EBA1C64A842BQ37945181-A9D04034-3CDB-4DF1-B89A-D93C1EA14AB3Q38551785-D7C38035-C7C3-4415-A285-74BBCFC73CA2Q38593985-7CCC526E-0517-4503-982F-5AE027A20F60Q38966422-C5C5F196-E39A-4DE9-8B9F-8B4D86F9489FQ39518387-FA9CC6C1-4907-44A2-913B-A3A5DCF3DCBAQ39684214-DC000A6D-D5F2-4FAC-BC95-3193795506C0Q41390340-9E74EC98-F113-42CB-9030-2B1F0E745C5BQ45094897-D506C839-BBB5-4665-B688-76AF79A5DBE3Q53834355-13CA4786-73D1-4E07-9DE0-32C308208F7CQ54295616-1099B393-900F-4627-A775-47756F076288Q54558551-A6AA910C-D302-4548-BBEC-26E39640BA73Q56787047-297F34D1-105F-4FFB-9D7D-3F0101056AA3Q59286551-5CCCDC8B-3F1D-4859-891A-61171622B7F1
P2860
The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
@en
type
label
The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
@en
prefLabel
The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
@en
P2093
P1433
P1476
The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
@en
P2093
Afifa Belaid
Amira Zairi
Clarisse Lorin
Françoise Baleux
Hakim Hocini
Héla Saidi
Khaled Hani
Laurent Bélec
P304
P356
10.1016/J.VIROL.2005.02.002
P407
P577
2005-04-01T00:00:00Z